C16orf55 Inhibitors
Compounds such as Wortmannin and LY294002 exert their effect by inhibiting PI3K, thereby attenuating Akt signaling, which can have downstream effects on proteins like C16orf55 that are regulated by this pathway. Similarly, molecules like Triciribine and Rapamycin exert their action through the Akt/mTOR pathway, which is known to regulate a multitude of cellular functions, including those associated with proteins like C16orf55.
Additionally, cell cycle inhibitors like Palbociclib and Roscovitine may impact C16orf55 by altering the cell cycle environment, which in turn could affect the stability and activity of this protein. Inhibition of signaling molecules such as JNK by SP600125, p38 MAPK by SB203580, and MEK by U0126 can lead to alterations in the cellular stress response, influencing the network in which C16orf55 operates. Compounds such as Dasatinib, which targets Src kinases, can also modify the activity of various signaling pathways that intersect with the biological processes involving C16orf55. Thapsigargin and Cyclopamine, by inducing ER stress and inhibiting the Hedgehog pathway respectively, can lead to changes in cellular homeostasis, which may affect the function or level of C16orf55 within the cell.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
An inhibitor of PI3K, which is upstream of Akt signaling; downregulation of Akt can lead to reduced phosphorylation and activation of downstream proteins, including C16orf55. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A synthetic molecule that inhibits PI3K, thus affecting the Akt pathway and subsequently influencing the function of proteins like C16orf55. | ||||||
Triciribine | 35943-35-2 | sc-200661 sc-200661A | 1 mg 5 mg | $104.00 $141.00 | 14 | |
Targets the Akt pathway, reducing phosphorylation levels and affecting the activity of proteins involved in this signaling cascade, including C16orf55. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor that can disrupt downstream signaling pathways, potentially affecting the cellular processes in which C16orf55 is involved. | ||||||
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
A CDK4/6 inhibitor that can arrest the cell cycle, thereby affecting the levels and activity of cell cycle-related proteins, which may include C16orf55. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $94.00 $265.00 | 42 | |
Inhibits CDKs and can alter the cell cycle and transcriptional regulation, which can influence the expression of C16orf55. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
A JNK inhibitor that can modify the JNK signaling pathway, potentially impacting the protein network that includes C16orf55. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor that can alter inflammatory and stress response pathways, possibly affecting C16orf55's role in these processes. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Inhibits MEK1/2 leading to the suppression of the ERK pathway, which can influence various proteins including C16orf55. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $70.00 $145.00 | 51 | |
A Src kinase inhibitor, which can affect multiple signaling pathways, including those regulating proteins like C16orf55. | ||||||